BANK VONTOBEL/CALL/ELI LILLY & CO/420/0.1/21.06.24 Stock

Warrant

DE000VU6BRA7

Delayed Deutsche Boerse AG 04:21:51 2024-05-23 am EDT
35.78 EUR +1.53% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/420/0.1/21.06.24
Current month+4.14%
1 month+16.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 35.78 +1.53%
24-05-22 35.24 -1.95%
24-05-21 35.94 +6.87%
24-05-20 33.63 +2.88%
24-05-17 32.69 -1.00%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 04:21 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VU6BRA
ISINDE000VU6BRA7
Date issued 2023-04-17
Strike 420 $
Maturity 2024-06-21 (30 Days)
Parity 10 : 1
Emission price 3.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 35.97
Lowest since issue 2.96
Spread 0.2
Spread %0.56%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
802.9 USD
Average target price
850.4 USD
Spread / Average Target
+5.92%
Consensus